<DOC>
	<DOCNO>NCT02462980</DOCNO>
	<brief_summary>Use AcQMap High Resolution Mapping Imaging System map persistent atrial fibrillation identify potential mechanistic target ablation .</brief_summary>
	<brief_title>Utilizing Novel Dipole Density Capabilities Objectively Visualize Etiology Rhythms Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion Criteria ( patient must ) : 1 . Be schedule ablation persistent atrial fibrillation due arrhythmia recurrent , poorly tolerate and/or unable control least one antiarrhythmic drug therapy . Persistent atrial fibrillation study define follow : 1 . AF last least 7 day 12 month without cardioversion Or 2 . AF last least 48 hour 12 month prior cardioversion terminate AF 2 . Be able willing give inform consent Exclusion Criteria ( patient must ) : 1 . Have history AF longer 12 month 2 . Have follow : 1 . Patients implanted prosthetic , artificial , repaired cardiac valve chamber map 2 . Patients implanted pacemaker ICD 3 . Patients history embolism inability tolerate anticoagulation therapy electrophysiology procedure 4 . Stents area pulmonary vein 3 . Have contraindication transfemoral venous access element AF ablation procedure 4 . Have contraindication transseptal leave atrial access include atrial septal occluder device 5 . Have leave atrial appendage occlusion device 6 . Have prior ablation atrial fibrillation 7 . NYHA class IV congestive heart failure 8 . Left ventricular ejection fraction ( LVEF ) &lt; 40 % 9 . Have rheumatic mitral valve disease 10 . Have leave atrial diameter &gt; 55 mm ( dimension ) 11 . Have myocardial infarction within prior three month 12 . Have atrial surgery ( include valve repair/replacement ) right leave atrium 13 . Have intracardiac thrombus ( must confirm via ultrasound prior map ) dense spontaneous echo contrast 14 . Have clinically significant severe tricuspid and/or mitral valve regurgitation moderate severe tricuspid and/or mitral valve stenosis 15 . Have prior stroke transient ischemic attack ( TIA ) systemic embolism 16 . Be pregnant nursing 17 . Have life expectancy le one year 18 . Be currently enrol clinical treatment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>